top of page

Semaglutide

Semaglutide: Clinically Proven Weight Loss Support
Semaglutide is a GLP-1 receptor agonist that helps regulate appetite and reduce food intake by promoting feelings of fullness and delaying gastric emptying. On average, users experience a 10–15% reduction in body weight with added metabolic and cardiovascular benefits.

Semaglutide – Targeted Weight Loss and Metabolic Wellness


At Metamorphosis, we offer Semaglutide, a GLP-1 receptor agonist that has transformed the landscape of medical weight loss. By mimicking the body’s natural GLP-1 hormone, Semaglutide works to suppress appetite, promote satiety, and regulate blood sugar levels—helping individuals achieve meaningful and sustainable weight reduction.


Average weight loss ranges from 10–15% of body weight, making it one of the most effective non-surgical options available for long-term weight management.

Additional benefits include:

  • Reduced hunger and food cravings

  • Lowered blood glucose levels

  • Delayed gastric emptying, prolonging feelings of fullness

  • Decreased cardiovascular risk factors

  • Lower risk of developing type 2 diabetes and stroke

Semaglutide is ideal for those seeking a medically guided, evidence-based approach to weight loss with added benefits for metabolic health and disease prevention.


To begin therapy, recent blood work (within the last 3–6 months) is required. Outside lab work is accepted.


Achieve lasting weight loss with clinically proven, hormone-based therapy.

bottom of page